An endoderm-specific transcriptional enhancer from the mouse Gata4 gene requires GATA and homeodomain protein binding sites for function in vivo by Rojas, Anabel et al.
An endoderm-specific transcriptional enhancer from the mouse
Gata4 gene requires GATA and homeodomain protein binding
sites for function in vivo
Anabel Rojas1,†, William Schachterle1, Shan-Mei Xu1, and Brian L. Black1,2,*
1Cardiovascular Research Institute, University of California, San Francisco, CA 94143-2240, USA
2Department of Biochemistry and Biophysics, University of California, San Francisco, CA
94143-2240, USA
Abstract
Several transcription factors function in the specification and differentiation of the endoderm,
including the zinc finger transcription factor GATA4. Despite its essential r ole in endoderm
development, the transcriptional control of the Gata4 gene in the developing endoderm and its
derivatives remains incompletely understood. Here, we identify a distal enhancer from the Gata4
gene, which directs expression exclusively to the visceral and definitive endoderm of transgenic
mouse embryos. The activity of this enhancer is initially broad within the definitive endoderm but
later restricts to developing endoderm-derived tissues, including pancreas, glandular stomach, and
duodenum. The activity of this enhancer in vivo is dependent on evolutionarily-conserved HOX and
GATA binding sites, which are bound by PDX-1 and GATA4, respectively. These studies establish
Gata4 as a direct transcriptional target of homeodomain and GATA transcription factors in the
endoderm and support a model in which GATA4 functions in the transcriptional network for pancreas
formation.
INTRODUCTION
The embryonic body of bilaterian animals is composed of three germ layers: ectoderm,
mesoderm and endoderm (Beddington and Smith, 1993). The endoderm gives rise to the
epithelia of the major part of the gut, which develops via a highly orchestrated process involving
numerous morphogenetic events, reciprocal interactions with the adjacent mesoderm and
ectoderm, and cell determination and differentiation (Bienz, 1997; Grapin-Botton and Melton,
2000; Wells and Melton, 2000; Stainier, 2002; Kumar et al., 2003). The result of these
patterning events is a gut tube in which defined regions are predetermined to contribute to
certain organs (Rosenquist, 1971; Keller, 1976; Lawson et al., 1986). At approximately
embryonic day (E) 9.5 in the mouse, many organs of the respiratory and gastrointestinal tracts,
including pancreas and stomach, begin to form as buds along the gut tube. These buds
subsequently expand and differentiate to form mature organs (Grapin-Botton and Melton,
2000). In the developing bud epithelia of the pancreas, growth and morphogenesis result in the
formation of small ductules, which contain the precursor cells of the acini, ducts, and islets of
Langerhans (Jonsson et al., 1995). The developing gut tube itself becomes regionalized along
the anterior-posterior axis, as cells adopt functions specific for their eventual roles in digestion
(Grapin-Botton and Melton, 2000). Although some of the embryological processes involved
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in the development of endoderm-derived organs are well understood, many of the molecular
events and transcriptional pathways controlling endoderm-derived organ development remain
undefined.
The homedomain transcription factor PDX-1 is one of the first markers of the developing
pancreas (Wright et al., 1989; Leonard et al., 1993; Ohlsson et al., 1993; Kim and MacDonald,
2002). PDX-1 is first observed in the mouse around E8.5 in the dorsal endoderm while the gut
is still an open tube. At E9.5, PDX-1 expression marks the dorsal and ventral pancreas buds
and the endoderm-derived component of the duodenum (Miller et al., 1994; Guz et al., 1995).
By E11.5, PDX-1 expression has expanded from the pancreas and duodenum to also include
the posterior part of the stomach (Stoffers et al., 1999). At later stages of development, when
the exocrine pancreas appears and hormone-producing cells are clustered in the islets, PDX-1
expression is restricted to the endocrine compartment where it plays a critical role in the
transcriptional regulation of the insulin gene (Ohlsson et al., 1993; Guz et al., 1995). In the
adult, PDX-1 expression is maintained in the duodenal epithelium and in insulin-secreting β-
cells in the islets (Hui and Perfetti, 2002). Mice lacking Pdx-1 display pancreatic agenesis and
have defects throughout the posterior foregut region, including a distorted gastro-duodenal
junction, loss of Brunner’s gland and deficiency of enteroendocrine differentiation in the
stomach and duodenum (Larsson et al., 1996; Offield et al., 1996; Jepeal et al., 2005). Loss of
PDX-1 function also results in pancreatic agenesis in human (Stoffers et al., 1997).
The GATA family of zinc finger transcription factors is also involved in the specification and
differentiation of the endoderm (Rehorn et al., 1996; Zhu et al., 1998; Reiter et al., 2001; Patient
and McGhee, 2002; Afouda et al., 2005; Watt et al., 2007). In vertebrates, three members of
this family, GATA4, 5, and 6 directly bind and activate endoderm genes, including gastric
H+/K+-ATPase, albumin, and HNF4 (Mushiake et al., 1994; Nishi et al., 1997; Morrisey et al.,
1998; Cirillo et al., 2002). Gata4 is expressed in the primitive endoderm, heart, liver, small
intestine, gastric epithelium and gonads (Arceci et al., 1993; Molkentin, 2000). Gata4 is also
expressed at the onset of mouse pancreas development and restricts to the exocrine pancreas
as development proceeds (Ketola et al., 2004; Decker et al., 2006). Gata4 expression is
observed in the duodenum and jejunum but is undetectable in the ileum; this gradient of GATA4
along the anterior-posterior axis is important for the maintenance of regional identities along
the gastrointestinal tract of adult mice (Bosse et al., 2006). In the adult duodenum, GATA4
directly activates the adenosine deaminase gene via a duodenum-specific enhancer, which is
also activated by the homedomain transcription factor PDX-1 (Dusing et al., 2001; Dusing et
al., 2003). In the adult stomach, Gata4 is expressed in the glandular portion, which comprises
the distal two-third of the stomach (Jacobsen et al., 2002). In this region, known as the hind
stomach, thousands of mucosal invaginations produce mucus and digestive enzymes (Nomura
et al., 1998; Larsson, 2000). Gata4 deficiency has been associated with impaired differentiation
into glandular epithelium in the developing stomach and intestine (Jacobsen et al., 2002;
Jacobsen et al., 2005).
Inactivation of Gata4 in the germline of mice leads to embryonic lethality around E10 as a
result of severe defects in extraembryonic endoderm, and Gata4-null mice display defects in
heart and foregut morphogenesis (Kuo et al., 1997; Molkentin et al., 1997). The use of tetraploid
complementation to overcome the early lethality in Gata4−/− embryos revealed additional roles
for GATA4 in mouse endoderm development (Watt et al., 2007). In Gata4−/− ES cell-derived
embryos, the liver bud fails to expand and the ventral pancreas is absent (Watt et al., 2007).
Similarly, an earlier study conducted using morpholino knockdown of Gata4 in the zebrafish
demonstrated an absolute requirement of Gata4 for the formation of multiple endoderm-
derived organs, including the liver and exocrine pancreas (Holtzinger and Evans, 2005). In
addition to its requirement for endoderm-derived organ development, GATA4 also plays a
later role in the function of the endoderm-derived small intestine by regulating jejunal
Rojas et al. Page 2
Dev Dyn. Author manuscript; available in PMC 2010 October 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
morphology and expression of genes involved in lipid metabolism in adult mice (Battle et al.,
2008)
Despite the importance of GATA4 in endoderm-derived organ development and gene
regulation, the transcriptional regulation of the Gata4 gene itself in the endoderm and its
derivative organs has not been defined. In the work described here, we identified an enhancer
from the mouse Gata4 gene that directs expression to the foregut in transgenic embryos. As
development proceeds, this novel Gata4 endoderm enhancer directs robust expression in the
regions of the gut that will give rise to the stomach and to the dorsal and ventral pancreases.
Later in development, the activity of this endoderm-specific regulatory element becomes
restricted to the glandular stomach, pancreatic exocrine acinar cells, and duodenal crypts. We
show that the Gata4 endoderm enhancer contains a conserved, tandem homeodomain
transcription factor (HOX) binding site and a perfectly conserved consensus GATA site. We
show that these cis-acting elements are bound efficiently by PDX-1 and GATA4, respectively.
Importantly, we show that the PDX/HOX and GATA binding sites are each independently
required for enhancer activity in transgenic embryos. Thus, these studies identify Gata4 as a
direct transcriptional target of homedomain and GATA transcription factors in vivo and support
a feed-forward transcriptional model for Gata4 regulation in the endoderm and its derivatives
in the pancreas, stomach, and duodenum.
RESULTS
A novel Gata4 endoderm-specific enhancer directs expression to the foregut and midgut in
vivo
To identify regulatory elements that control Gata4 expression in vivo, we compared the
sequences of the mouse, human, and opossum Gata4 loci using BLAST and VISTA analyses
(Altschul et al., 1990; Mayor et al., 2000). The comparison showed at least nine major regions
of conservation in non-coding sequences, referred to as G1–G9, within the Gata4 locus (Fig.
1). Because these sequences have been conserved since placental and marsupial mammals
diverged approximately 150 million years ago (Graves, 1996), we hypothesized that one or
more of these sequences might be important regulatory modules. To test this notion, we cloned
each of these regions into the transgenic reporter plasmid Hsp68-lacZ (Kothary et al., 1989)
and tested for enhancer activity in transgenic mouse embryos. These studies identified several
unique and highly specific transcriptional enhancers, including a previously described lateral
mesoderm enhancer regulated by Forkhead and GATA transcription factors (Rojas et al.,
2005).
We also identified a unique endoderm enhancer from the mouse Gata4 locus, which we refer
to as Gata4 G8. The Gata4 G8 genomic fragment spans 3541 bp and is located approximately
80 kb upstream of the Gata4 transcriptional start site (Fig. 1). At E9.5, Gata4 G8 directed
lacZ expression to the ventral and dorsal foregut, midgut (Fig. 2A–C, E), and yolk sac (data
not shown). β-galactosidase expression was also observed in the foregut-derived ventral
pancreatic bud entering the septum transversum just below the developing heart (Fig. 2B,
arrowhead). The expression of endogenous GATA4 protein expression completely overlapped
the expression of the Gata4-G8-lacZ transgene in the foregut and midgut at E9.5, although the
expression of endogenous GATA4 was broader than transgene expression (Fig. 2, compare
panels C, E to panels D, F). The broader expression of endogenous GATA4 likely reflects
control of the Gata4 gene by additional modular transcriptional enhancers, which control
expression in distinct subsets of the developing gut mesoderm and endoderm.
By E11.5, the broad pattern of Gata4 G8 enhancer activity became restricted to the epithelium
of the stomach, with the strongest expression in the hind stomach, and to the nascent pancreatic
epithelium (Fig. 2G, I). The epithelia of the hind stomach and the pancreas are marked by the
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expression of PDX-1 at E11.5 (Ashizawa et al., 2004), and β-galactosidase expression directed
by Gata4 G8 overlapped PDX-1 positive cells almost perfectly at that stage (Fig. 2I, J).
Importantly, no Gata4-G8-lacZ transgene expression was observed in the mesenchyme of
these developing organs, suggesting that the activity of the enhancer is endoderm-specific. By
E13.5, expression directed by the Gata4 G8 endoderm-specific enhancer appeared only in the
glandular (hind) stomach and was absent in the anterior portion of the stomach, (Fig. 2K),
which corresponded almost precisely to endogenous GATA4 protein expression in the stomach
(Fig. 2L). At this stage, Gata4 G8-directed β-galactosidase expression was also very robust in
the branching epithelial tree of the dorsal and ventral pancreases (Fig. 2H, M), and comparison
of immediately adjacent sections stained for expression of endogenous GATA4 and PDX-1
proteins showed that the pattern of β-galactosidase expression overlapped with endogenous
GATA4 almost perfectly (Fig. 2N). β-galactosidase expression also overlapped the expression
PDX-1 protein (Fig. 2O), which is important since PDX-1 is a marker of endoderm-derived
pancreatic epithelium at this stage (Ashizawa et al., 2004).
Gata4 G8 endoderm enhancer activity restricts to the gastric epithelium, duodenal crypts,
and pancreatic acinar cells
At E18.5, the activity of the Gata4 endoderm enhancer remained robust in the epithelium of
the glandular stomach, which again, tightly mirrored endogenous GATA4 expression (Fig. 3A,
B). Indeed, expression of both Gata4-G8-lacZ and endogenous GATA4 could be seen
throughout the epithelial invaginations in the hind stomach but not in the underlying gastric
mesenchyme (Fig. 3A, B). Similarly, transgene-directed β-galactosidase expression in the
duodenum was restricted to the endoderm component and tightly overlapped endogenous
GATA4 expression in this intestinal compartment (Fig. 3C, D).
By later stage in fetal development, the pancreas has developed clearly distinct endocrine and
exocrine compartments (Kim and MacDonald, 2002). The exocrine pancreas is marked by the
expression of acinar cell digestive enzymes, such as amylase. In contrast, differentiation of the
endocrine pancreas results in a large increase in the number of hormone-producing cells (Kim
and MacDonald, 2002). PDX-1 becomes restricted to a subset of exocrine acinar cells and
endocrine cells during fetal development and its expression becomes progressively more
restricted to insulin-producing β-cells (Ashizawa et al., 2004). By E18.5, strong expression of
PDX-1 can be seen in β-cells, while only low levels are detectable in the nuclei of acinar cells
(Ashizawa et al., 2004). Therefore, we examined the overlap of Gata4 G8-directed expression
in the pancreas with endogenous GATA4 and with markers of the endocrine and exocrine
pancreases. Endogenous GATA4 protein and Gata4-G8-lacZ transgene expression within the
pancreas was confined to the exocrine acinar cells, marked by the expression of amylase (Fig.
3E, G). By contrast, neither GATA4 nor β-galactosidase protein was detected in insulin-
producing cells (Fig. 3E, F; arrowheads). Importantly, this expression pattern essentially
mirrored the expression of endogenous GATA4 protein within the pancreas at this stage (Fig.
3F). PDX-1 protein expression began to become restricted to islets within the pancreas at E18.5
(Fig. 3H, arrowheads), although some expression of PDX-1 was still observed within acinar
cells (Fig. 3H, arrows). The reduced expression of PDX-1 in acinar cells coincided with the
weaker expression of Gata4-G8-lacZ compared to earlier stages in development, hinting at a
possible regulatory relationship between PDX-1 and Gata4.
Importantly, the overlap of the Gata4-G8-lacZ transgene expression with endogenous GATA4
protein expression throughout the development of the gut and pancreas strongly supports the
notion that the Gata4 G8 enhancer is a bona fide regulatory element controlling expression of
Gata4. In addition, the overlap of Gata4 G8 enhancer activity with PDX-1 expression,
suggested the possibility that Gata4 might be regulated in a common transcriptional pathway
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with the homeodomain protein PDX-1 and that this molecular circuitry might function via the
G8 enhancer.
The Gata4 endoderm enhancer contains deeply conserved HOX and GATA binding sites
As a first step toward defining a transcriptional pathway upstream of Gata4 in the endoderm,
we determined the minimal region of the G8 enhancer sufficient to direct endoderm-specific
expression. The G8 enhancer contains two regions that are conserved between human, mouse,
and opossum, denoted CR1 and CR2 (Fig. 4A). We deleted the majority of the 5′ end of the
G8 enhancer, including the CR1 conserved region, to generate a smaller fragment, referred to
as G8[890], which contains 890 bp from the 3′ end of G8, extending from nucleotides 2652 to
3541. We examined the ability of G8[890], which includes the entire CR2 conserved region,
to direct expression in transgenic embryos. At E9.5, this smaller construct directed robust
lacZ expression to the ventral and dorsal foregut, as well as the midgut, in a pattern identical
to full-length G8 (Fig. 4B, C). At E11.5, Gata4-G8[890]-lacZ expression was restricted to the
stomach and pancreas (data not shown), which was also consistent with the expression of the
larger Gata4-G8-lacZ transgene. A fragment lacking the CR2 region, but encompassing all of
CR1 showed no activity in transgenic embryos (data not shown). These results demonstrate
that G8[890] is sufficient to direct expression to the developing gut at E9.5 and to the stomach,
ventral and dorsal pancreases, and duodenum at E11.5. These observations suggest that the
minimal, essential cis-regulatory elements of this Gata4 endoderm enhancer reside within CR2.
We examined CR2 for candidate transcription factor binding sites and for cross-species
conservation. Interestingly, CR2 contains two overlapping candidate HOX binding sites (2x
HOX) and one candidate GATA transcription factor binding site (Fig. 4D). Because the
expression pattern of Gata4-G8-lacZ largely overlapped the expression of PDX-1 from the
onset of foregut formation through pancreas, stomach, and duodenum development, we
reasoned that PDX-1 might bind to the Gata4 enhancer via the overlapping HOX sites
contained within G8 CR2. To test this possibility, we examined the ability of PDX-1 protein
to bind to the HOX sites in the Gata4 endoderm enhancer by EMSA (Fig. 5A). PDX-1 bound
efficiently to a probe encompassing the two overlapping HOX sites in Gata4 G8 (Fig. 5A, lane
8). Binding was specific because it was competed by excess unlabeled control HOX site (Wang
et al., 2004) and by excess unlabeled G8 2x HOX self-probe (Fig 5A, lanes 9, 11). By contrast,
binding of PDX-1 to the Gata4 G8 2x HOX site was not competed by unlabeled mutant versions
of the PDX-1 control site or the Gata4 HOX sites (Fig. 5A, lanes 10, 12). In addition, the
Gata4 G8 2x HOX site efficiently competed for PDX-1 binding to a control PDX site from
the lactase gene promoter (Wang et al., 2004; Fig. 5A, lane 5), further confirming the ability
of the Gata4 G8 2x HOX site to be bound efficiently by PDX-1.
In addition to PDX-1 binding to the 2x HOX site in the enhancer, GATA4 bound to the G8
enhancer via the conserved GATA site (Fig. 5B, lane 8). Binding of GATA4 to the GATA site
in the Gata4 endoderm enhancer was specific since binding was efficiently competed by excess
unlabeled GATA control probe (Rojas et al., 2005;Fig. 5B, lane 9) and by excess unlabeled
self-probe (Fig. 5B, lane 11) but not by mutant versions of the control or Gata4 CR2 GATA
probes (Fig. 5B, lanes 10, 12). The Gata4 G8 GATA site also efficiently competed for GATA4
binding to the bona fide GATA binding site from the Gata4 G2 lateral mesoderm enhancer
(Rojas et al., 2005; Fig. 5B, lane 5) but a mutant version of the G8 GATA site did not compete
for binding to the control GATA site (Fig. 5B, lane 6). Thus, the results presented in Fig. 5
demonstrate that the HOX and GATA sites in the Gata4 G8 endoderm enhancer are efficiently
and specifically bound in vitro by PDX-1 and GATA4, respectively.
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Gata4 endoderm enhancer function is dependent on HOX and GATA binding sites in vivo
To test the requirement of the HOX and GATA sites in G8 for enhancer activity in vivo, we
generated transgenic embryos harboring Gata4-G8-lacZ transgenes with mutations in either
the 2x HOX or the GATA sites in the context of the full-length G8 fragment (Fig. 6). The
mutations were identical to those used in the EMSA analyses, where they mutations abolished
PDX-1 and GATA4 binding (Fig. 5). At E11.5, the wild-type Gata4-G8-lacZ transgene
directed robust expression to the epithelium of the stomach and pancreas (Fig.6A, B). In
contrast, mutation of the two tandem HOX sites in the enhancer resulted in a complete
disruption of enhancer activity (Fig. 6C, D). Similarly, mutation of the GATA site abolished
enhancer activity (Fig. 6E, F). These data demonstrate that the HOX and GATA sites in CR2
are required for Gata4 G8 endoderm enhancer function in vivo. Taken together with the data
from the EMSA in Fig. 5, these observations suggest that Gata4 is a transcriptional target of
PDX-1 and GATA factors via direct binding to the Gata4 G8 endoderm enhancer.
DISCUSSION
A model for pancreas development involving FoxA2, GATA4, and PDX-1
The formation of organ primordia along the length of the developing gut tube requires sub-
specification of the early definitive endoderm and the proper activation of several overlapping
but discrete transcriptional programs in the developing embryo (Kumar and Melton, 2003;
Servitja and Ferrer, 2004). Precisely how this is achieved remains unclear, but several key
regulators have been identified as playing important roles in endoderm development. Among
these, Gata4 is one of the earliest markers of the endoderm and regulates the proliferation and
differentiation of many endoderm-derived cell types (Arceci et al., 1993; Heikinheimo et al.,
1994; Maduro and Rothman, 2002; Nemer and Nemer, 2003; Heicklen-Klein and Evans,
2004; Murakami et al., 2005; Zorn and Wells, 2007). In the mouse, inactivation of Gata4 causes
cardia bifida due to severe defects in endoderm differentiation and migration (Kuo et al.,
1997; Molkentin et al., 1997), and GATA4 has been implicated in the development of several
endoderm-derived organs (Rehorn et al., 1996; Zhu et al., 1998; Reiter et al., 2001). Similarly,
the Forkhead transcription factor FoxA2 is an essential regulator of endoderm development
through its role as a pioneer factor capable of reconfiguring chromatin to an active state (Cirillo
et al., 1998). Interestingly, FoxA2 functions cooperatively with GATA4 to define the
competency of the endoderm to adopt a hepatic fate (Bossard and Zaret, 1998; Zaret, 1999;
Cirillo et al., 2002). However, Gata4 and Foxa2 are co-expressed broadly throughout the
endoderm, suggesting that other factors may be important to restrict or refine the activity of
FoxA2 and GATA4 to give rise to different organ primordia (Zaret, 2008). In this regard,
PDX-1 appears to be the critical factor for promoting a pancreatic fate in the early definitive
endoderm (Miller et al., 1994; Guz et al., 1995; Larsson et al., 1996; Offield et al., 1996;
Stoffers et al., 1997). An attractive model for pancreatic development would involve FoxA2
and GATA4 functioning cooperatively to reposition nucleosomes in the Pdx1 locus only in
regions of the developing gut that also receive additional spatially-restricted signals. This
would allow GATA4 and FoxA2 to promote pancreatic gene expression, followed by
amplification of the program via PDX-1 activation of Gata4 and possibly Foxa2 as well.
Our EMSA data (Fig. 5) clearly demonstrate that GATA4 and PDX-1 bind to their respective
sites in the Gata4 G8 enhancer, and our mutagenesis data show that the GATA and HOX (PDX)
sites in the Gata4 G8 enhancer are absolutely required for enhancer function in vivo (Fig. 6).
Together, these observations support our model for PDX-1/GATA-dependenent regulation of
Gata4 in the endoderm and its derivatives. The very strong overlap in the expression directed
by the Gata4 G8 enhancer and PDX-1 and GATA4 further support this notion. However, it
remains possible that other transcription factors, in addition to or in lieu of, GATA4 and PDX-1
may regulate the Gata4 G8 enhancer in vivo via the essential cis-acting elements described in
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these studies. Taken together, however, the data presented here suggests that Gata4 expression
is activated and maintained by the combined activities of PDX-1 and GATA4 via essential
binding sites within the Gata4 G8 enhancer and are consistent with a feed-forward model for
endoderm differentiation. Alternatively, Gata4 expression may be activated by other GATA
factors, such as GATA6, which is also expressed in the developing pancreas at early stages
(Decker et al., 2006). It will be interesting to determine whether GATA4 and other GATA
factors may also contribute to pancreas specification and differentiation via direct activation
of Pdx1 and other endoderm- and pancreas-restricted transcription factor genes.
Modular regulation of Gata4 by multiple, independent enhancers
During embryonic development, Gata4 is expressed in multiple tissues with dynamic and
distinct patterns of expression in different cell lineages (Arceci et al., 1993; Molkentin,
2000). The Gata4 endoderm enhancer described here directs expression throughout the foregut
and midgut at early stages of development but becomes restricted to the epithelia of pancreas,
stomach, and duodenum as development proceeds (Fig. 2, Fig 3). This type of progressive
restriction from an initially broad pattern to a narrow pattern may be a common theme in the
regulation of enhancers present in the Gata4 gene, as a similar phenomenon was observed in
the expression directed by the previously identified Gata4 G2 mesoderm enhancer (Rojas et
al., 2005). The rapid restriction of enhancer activity suggests that the activators of the G8
enhancer may also become restricted as cells within the endoderm differentiate and adopt a
more restricted fate. Alternatively, the restriction of Gata4 enhancer activity might be
explained by the action of repressors that impair the activation of the enhancer in some cell
types.
The activity of the Gata4 G8 enhancer is restricted to a subset of the endogenous Gata4
expression pattern, suggesting that other Gata4 enhancers direct expression to other endoderm
and mesoderm derivatives where the Gata4 gene is normally expressed. Our previous
identification of a discrete Gata4 enhancer that recapitulates endogenous GATA4 protein
expression in the lateral mesoderm and its derivates in the liver mesenchyme supports this
notion (Rojas et al., 2005). It is likely that additional modular enhancers from the Gata4 locus
will regulate Gata4 expression in the mesoderm and endoderm. Indeed, we have recently
identified an additional endoderm enhancer from Gata4 with distinct spatiotemporal activity
compared to the G8 enhancer described here (AR and BLB, unpublished observations).
Understanding how the activity of these different modular regulatory elements are integrated
and controlled during development will be an important area for future studies to define the
precise regulation of the Gata4 gene in vivo.
EXPERIMENTAL PROCEDURES
Cloning and mutagenesis
The 3541-bp G8 fragment of the mouse Gata4 gene was generated by PCR using the following
two primers: 5′-caggcaccactcgagttctggaaac-3′ and 5′-gtttctctttcccgggacctctggaag-3′. This
fragment was then cloned as an XhoI-XmaI fragment into the transgenic reporter plasmid
Hsp68-lacZ (Kothary et al., 1989) to create plasmid Gata4-G8-Hsp68-lacZ. The following
mutant sequences were created in the context of the G8 transgene: m-HOX, 5′-
gttcacaggacacccactagtcaaacagttccc-3′; m-GATA 5′-ctttggtctcagcttaagaaactgccctg-3′. The
sequence of each mutant fragment was confirmed by sequencing on both strands. The GenBank
accession number for the sequence of the mouse Gata4 G8 endoderm enhancer described in
this manuscript is currently pending.
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Generation of transgenic mice
Transgenic reporter constructs were digested from the Gata4-G8-Hsp68-lacZ plasmid
backbone with SalI to create Gata4-G8-lacZ and with SphI and SalI to create Gata4-G8
[890]-lacZ, gel purified, and suspended in 5 mM Tris-HCl, 0.2 mM EDTA, pH7.4, at a
concentration of 2 µg/ml for pronuclear injection, as described previously (Dodou et al.,
2003). Injected embryos were implanted into pseudopregnant CD-1 females, and embryos were
collected at indicated developmental stages for transient analyses or were allowed to develop
to adulthood for the establishment of stable transgenic lines. DNA was extracted from the yolk
sac of embryos or from tail biopsies from mice by digestion in tail lysis buffer (100 mM NaCl,
25 mM EDTA, 1% sodium dodecyl sulfate, 10 mM Tris-Cl, 200 µg/ml proteinase K, pH 8.0)
at 56°C overnight. Digested samples were extracted once with phenol-chloroform and ethanol
precipitated. The presence of the lacZ transgene was detected by Southern blot. All experiments
using animals complied with federal and institutional guidelines and were reviewed and
approved by the UCSF Institutional Animal Care and Use Committee.
X-gal staining, H&E and immunohistochemistry
β-galactosidase activity in lacZ transgenic embryos or tissues was detected by X-gal staining,
which was performed as described previously (Dodou et al., 2003). Transverse and sagittal
sections from X-gal stained embryos and tissues were prepared and counterstained with Neutral
Fast Red as described previously (Anderson et al., 2004). For immunohistochemistry, sections
were dewaxed, incubated in PBS for 5 min, boiled in antigen retrieval solution (Biogenex),
and blocked in 3% normal goat serum for 1 h. Incubation with the following primary antibodies
was done overnight at 4°C in a humid chamber at a 1:300 dilution: rabbit anti β-galactosidase
(ICN), rabbit anti-amylase (Sigma), goat anti-GATA4 (Santa Cruz Biotechnologies), guinea
pig anti-insulin (Linco), and rabbit anti-PDX-1 (kind gift of M. German, UCSF). Following
incubation with primary antibodies, sections were washed three times with PBS and incubated
with appropriate secondary antibodies, including Alexa Fluor 488 donkey anti-goat
(Invitrogen), Alexa Fluor 594 donkey anti-rabbit (Invitrogen), Oregon Green 488 goat anti-
rabbit (Invitrogen), andCyanine 5 (Cy5)-conjugated anti-guinea pig (Invitrogen) at 1:300
dilutions in 3% normal goat serum at room temperature for 1 h. Slides were then washed three
times in PBS, mounted using SlowFade Light antifade (Molecular Probes) and photographed
on a fluorescence microscope. Immunoperoxidase staining was performed using the Vectastain
Elite ABC kit and developed using the peroxidase substrate DAB (Vector Laboratories).
Electrophoretic mobility shift assay (EMSA)
DNA binding reactions were performed as described previously (Dodou et al., 2003). Briefly,
double-stranded oligonucleotides were labeled with [32P]-dCTP, using Klenow to fill in the
overhanging 5′ ends, and then purified on a nondenaturing polyacrylamide-TBE gel. Binding
reactions were pre-incubated at room temperature in 1X binding buffer (40mM KCl, 15mM
HEPES [pH 7.9], 1mM EDTA, 0.5 mM DTT, 5% glycerol) containing recombinant protein,
1.5 µg of poly-dI:dC and competitor DNA for 10 min prior to probe addition. Reactions were
incubated for an additional 20 min at room temperature after probe addition and were then
electrophoresed on a 6% nondenaturing polyacrylamide gel.
The Gata4 and Pdx-1 cDNAs were transcribed and translated using the TNT Coupled
Transcription-Translation System (Promega), as described in the manufacturer’s directions.
GATA4 protein was generated from pCITE-GATA4 plasmid, which has been described
previously (Dodou et al., 2004). PDX-1 protein was generated from pBat-PDX-1 plasmid
(kindly provided by M. German, UCSF) using T7 polymerase. The sense strand sequences of
the mouse Gata4 G8 GATA and HOX sites used for EMSA were: GATA: 5′-
ggctttggtctcagcttatcaaactgccctg-3′; HOX: 5′-ggcaggttcacaggacacccattaatcaaacagttccc-3′. The
sense strand sequences of the GATA and HOX mutant sites were the same as for the mutagenic
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primers described above. The GATA control site used here was the gata I site from the
Gata4 G2 lateral mesoderm enhancer, which has been described previously (Rojas et al.,
2005). The PDX control site from the rat lactase gene has also been described previously
(Wang et al., 2004).
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Fig.1.
VISTA plot and schematic representation of the mouse Gata4 locus and the Gata4-G8-lacZ
transgene. The top of the figure shows VISTA plots (Mayor et al., 2000) comparing the
sequence conservation between the mouse and opossum and the mouse and human Gata4 loci.
The red circled regions represent regions of the mouse Gata4 locus that were tested for enhancer
activity in transgenic embryos, including the G8 region, which is the foucus of the present
study. The horizontal line in the middle of the figure represents the mouse Gata4 locus. Exons
are depicted as vertical black lines. The bent arrow represents the transcriptional start. The red
boxes (G1–G9) represent nine regions of non-coding sequence, which are highly conserved
between the human, mouse, and opossum Gata4 sequences. The lower line depicts the
Gata4-G8-lacZ transgene.
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Fig.2.
The Gata4-G8-lacZ transgene is expressed in the foregut and midgut and its derivatives in the
developing stomach, pancreas, and duodenum during mouse embryonic development. Whole
mount (A, H), sagittal (B, G, K) and transverse (C, E) sections of X-gal-stained Gata4-G8-
lacZ transgenic embryos or dissected organs from transgenic embryos are shown. For
comparison, transverse (D, F, M, N, O) and sagittal (I, J, L) sections stained with α–β-
galactosidase, α–GATA4, and α–PDX-1 antibodies are shown. Arrows mark the developing
gut. The dashed lines and asterisks in (C, D) show regions of the gut mesoderm marked by
endogenous GATA4 expression (D) but not by the activity of the modular Gata4 G8 enhancer
(C) in the corresponding region of the mesoderm. Arrowheads mark the nascent pancreatic
epithelium. Expression of Gata4-G8-lacZ was confirmed at each stage in four independent
transgenic lines, which showed nearly identical patterns of expression at all stages. Bars in all
panels are equal to 100 µm. Expression of Duod, duodenum; hrt, heart; Panc, pancreas; Stom,
stomach.
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Fig.3.
Gata4 G8 endoderm enhancer activity is restricted to the glandular stomach, crypts of the
duodenum, and pancreatic acinar cells at E18.5. Transverse sections of stomach (A, B),
duodenum (C, D) and pancreas (E–H) were stained with X-gal (A, E), α–β-galactosidase (C),
α–GATA4 antibody (B, D, F), α-Insulin antibody (F), α–amylase antibody (G), or α–PDX-1
antibody (H). Gata4-G8-lacZ transgene expression was apparent in the glandular stomach and
crypts of the duodenum (arrows in A and C), which overlaps with the expression of the
endogenous GATA4 (arrows in B and D). In the pancreas, expression was restricted to acinar
cells (arrows in E, G, H), marked by amylase positive cells (G). Islets (arrowheads in E, F, H),
marked by Insulin expression (F) and PDX-1 expression (H) were negative for β-galactosidase
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expression (E). Gata4-G8-lacZ expression was nearly identical to the expression of
endogenous GATA4, which was also restricted to acinar cells (green staining in F) and was
excluded from the Insulin-producing cells and PDX-1-positive cells (arrowheads in F and H,
respectively). Expression of Gata4-G8-lacZ was confirmed at this stage in four independent
transgenic lines, which showed nearly identical patterns of expression. Bars in all panels are
equal to 100 µm.
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Fig.4.
The Gata4 G8 endoderm enhancer contains a highly conserved region that is sufficient for
enhancer activity in vivo. (A) The top line represents the genomic organization of the G8
enhancer. Red boxes represent two regions of high conservation between the human, mouse,
and opossum Gata4 sequences, denoted CR1 and CR2. Schematic diagram of the G8 enhancer
and a deletion construct G8[890]. The nucleotide positions of the G8 and G8[890] are denoted
to the left. The column on the right indicates the number of independent transgenic lines or F0
embryos that expressed lacZ in the primitive gut at E9.5 and in the stomach, pancreas, and
duodenum at E11.5 as a fraction of the total number of transgene-positive embryos. (B, C)
Representative, X-gal-stained G8 and G8[890] transgenic embryos. The G8 and G8[890]
constructs directed robust expression in the developing gut (arrows). (D) ClustalW analysis of
the Gata4 G8 CR2 sequence, comparing the mouse, human, and opossum sequences. CR2
contains two conserved, overlapping candidate HOX binding sites (2x HOX, blue box) and
one conserved, candidate GATA binding site (red box). Asterisks denote nucleotides that have
been perfectly conserved among the three species.
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Fig.5.
The Gata4 G8 endoderm enhancer is bound by PDX-1 and GATA4. (A) Recombinant PDX-1
protein was used in EMSA with a radiolabeled, double-stranded oligonucleotide probe
encompassing a canonical PDX-1 binding site from the promoter of the lactase gene (lanes 1–
6) or the Gata4 G8 2x HOX site (lanes 7–12). Lanes 1 and 7 contain reticulocyte lysate without
recombinant PDX-1 (represented by a minus sign). PDX-1 efficiently bound to the control
PDX site and to the Gata4 G8 2x HOX site (lanes 2, 8). Binding was competed by excess
unlabeled control site (C, lanes 3 and 9) or unlabeled Gata4 2x HOX site (G8, lanes 5 and 11),
but not by an excess of unlabeled mutant control site (mC, lanes 4 and 10) or mutant G8 2x
HOX site (M, lanes 6 and 12). (B) Recombinant GATA4 protein was used in EMSA with a
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radiolabeled double-stranded oligonucleotide probe representing a canonical GATA binding
site from the Gata4 G2 lateral mesoderm enhancer (lanes 1–6) or the Gata4 G8 GATA site
(lanes 7–12). Lanes 1 and 7 contain reticulocyte lysate without recombinant GATA4 protein.
GATA4 efficiently bound to the GATA control site and to the Gata4 G8 GATA site (lanes 2,
8). In both cases, binding was competed by excess, unlabeled control GATA site (C, lanes 3
and 9) or unlabeled Gata4 G8 GATA site (G8, lanes 5 and 11), but not by excess unlabeled
mutant control GATA site (mC, lanes 4 and 10) or an unlabeled mutant version of the Gata4
G8 GATA site (M, lanes 6 and 12).
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Fig.6.
The Gata4 G8 endoderm enhancer is dependent on conserved HOX and GATA sites for activity
in vivo. Wild-type and mutant versions of the Gata4-G8-lacZ transgenes were used to generate
transgenic embryos. Representative X-gal-stained whole mount (A, C, E) or sagittally
sectioned (B, D, F) transgenic embryos at E11.5 are shown. The wild-type construct directed
strong expression in the stomach (A, B, arrow) and in the nascent pancreatic epithelium (B,
arrowhead) in four independent transgenic lines. Mutation of the 2x HOX site in the Gata4 G8
enhancer (mHOX) abolished the expression in all five independently generated embryonic
transgenic lines analyzed (C, D). Similarly, mutation of the Gata4 G8 GATA site completely
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eliminated transgene expression in all four independently-generated embryonic transgenic
lines analyzed (E, F). The bars in panels B, D, and F are equal to 100 µm.
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